Welcome to our dedicated page for AMERICAN HEALTHCARE REIT SEC filings (Ticker: AHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for American Healthcare REIT, Inc. (NYSE: AHR), a healthcare-focused real estate investment trust. As an issuer with common stock registered under Section 12(b) of the Securities Exchange Act of 1934, American Healthcare REIT files current reports on Form 8-K and other documents that disclose material events, financial results, capital markets transactions, governance matters and distribution declarations.
In its Form 8-K filings, the company reports quarterly earnings releases and supplemental financial data, including metrics such as GAAP net income attributable to controlling interest, Normalized Funds from Operations (NFFO) per diluted share and Same-Store Net Operating Income (NOI) growth by segment. Filings also describe acquisition and development activity across its integrated senior health campuses (ISHC), outpatient medical, triple-net leased properties and senior housing operating properties (SHOP) segments, as well as lease buyouts and dispositions of non-core properties.
American Healthcare REIT’s SEC filings further detail capital markets activity, such as public offerings of common stock on a forward basis, at-the-market (ATM) equity offering programs and related underwriting and forward sale agreements. The company discloses how it intends to contribute net proceeds to its operating partnership for general corporate purposes, including potential future investments. Additional filings report on quarterly cash distributions authorized by the board of directors, annual meeting voting results, equity plans and corporate responsibility reporting.
On Stock Titan, AI-powered tools can help interpret these filings by summarizing key terms, highlighting segment-level performance disclosures and clarifying the implications of equity offerings, distributions and governance actions. This allows readers to review American Healthcare REIT, Inc.’s regulatory history and understand how the company describes its financial condition, portfolio management and capital structure in official SEC documents.
American Healthcare REIT, Inc. entered into an additional forward sale agreement covering 1,215,000 shares of its common stock in connection with the full exercise of the underwriter’s option from a previously closed public offering of 8,100,000 shares. A forward seller borrowed and sold these 1,215,000 shares to hedge the forward purchaser’s obligations.
The company currently plans to deliver 1,215,000 shares to the forward purchaser on one or more dates no later than May 20, 2027, in exchange for cash based on the public offering price, less underwriting discounts and commissions and subject to adjustments. The company intends to contribute the net proceeds to its operating partnership, which plans to use the funds for general corporate purposes, including potential future investments.
American Healthcare REIT, Inc. closed a public offering of 8,100,000 shares of its common stock through a forward sale structure. Under an underwriting agreement with RBC Capital Markets and an affiliate acting as forward purchaser, the shares were borrowed and sold on November 24, 2025 to hedge the forward sale agreement.
The company expects, subject to its right to elect cash or net share settlement, to deliver 8,100,000 shares to the forward purchaser on one or more dates no later than May 20, 2027 in exchange for cash proceeds per share based on the public offering price, less underwriting discounts and commissions and subject to adjustments. The underwriters also have a 30-day option to purchase up to 1,215,000 additional shares.
The company intends to contribute the net proceeds from settling the forward sale agreement to its operating partnership in exchange for limited partnership units, and the operating partnership plans to use these funds for general corporate purposes, including potential future investments.
American Healthcare REIT, Inc. is offering 8,100,000 shares of common stock through a forward sale agreement with Royal Bank of Canada, with up to 9,315,000 shares if the underwriter’s option is fully exercised. The forward purchaser or its affiliate will initially borrow and sell the shares to the underwriter at an initial forward sale price of $47.75 per share, and the company will receive no proceeds from that sale.
Assuming full physical settlement of the forward sale agreement within approximately 18 months, the company estimates net cash proceeds of about $386.4 million, or $444.4 million if the option is fully exercised, based on the $47.75 initial forward price. After settlement, total common stock outstanding is expected to be 186,264,566 shares, compared with 178,164,566 shares outstanding as of November 14, 2025.
The company plans to contribute the net proceeds to its operating partnership for general corporate purposes, including potential healthcare real estate investments. As a REIT, it maintains a 9.9% ownership limit on its capital stock to help preserve REIT status, and warns that the forward structure can create dilution and, in certain cash or net share settlement scenarios, potential cash or share obligations to the forward purchaser.
American Healthcare REIT, Inc. is offering 8,100,000 shares of common stock, with an additional 1,215,000-share option, through a forward sale agreement with Royal Bank of Canada. The forward purchaser will borrow and sell the shares now, while the company expects to physically settle the agreement and receive cash proceeds within about 18 months, although it can instead choose cash or net share settlement, which could result in no proceeds and potential cash or share payments to the bank.
Shares outstanding were 178,164,566 as of November 14, 2025, and are expected to be 186,264,566 after full physical settlement. AHR continues to expand, having closed over $575 million of acquisitions in 2025 and holding a $288.5 million pipeline, supported by a $1.0 billion at-the-market program and prior forward sales for 2,153,436 shares.
American Healthcare REIT, Inc. is offering 8,100,000 shares of common stock, with an additional 1,215,000-share option, through a forward sale agreement with Royal Bank of Canada. The forward purchaser will borrow and sell the shares now, while the company expects to physically settle the agreement and receive cash proceeds within about 18 months, although it can instead choose cash or net share settlement, which could result in no proceeds and potential cash or share payments to the bank.
Shares outstanding were 178,164,566 as of November 14, 2025, and are expected to be 186,264,566 after full physical settlement. AHR continues to expand, having closed over $575 million of acquisitions in 2025 and holding a $288.5 million pipeline, supported by a $1.0 billion at-the-market program and prior forward sales for 2,153,436 shares.
American Healthcare REIT (AHR) executive Mark E. Foster (EVP, GC & Secretary) reported an open-market sale of 1,500 shares of common stock on 11/11/2025 at a $49.3531 weighted average price (Transaction Code: S).
The sale was executed in multiple trades between $49.35 and $49.37. Following the transaction, Foster beneficially owns 57,600 shares directly.
American Healthcare REIT (AHR) received a Form 144 notice indicating a planned sale of 1500 common shares. The filing lists an aggregate market value of 74030, with an approximate sale date of 11/11/2025 on the NYSE, using broker Merrill (8890 Lyra Drive, Columbus, OH).
The shares to be sold were acquired via Restricted Stock Vesting on 03/25/2025 in the amount of 1500. Over the prior three months, a related sale shows 3850 common shares with gross proceeds of 161156 by Mark Foster. The table also lists 176908238 shares outstanding.
Form 144 is a notice of intent to sell restricted or control securities and is an administrative disclosure rather than a financing transaction.
American Healthcare REIT, Inc. (AHR) received an amended Schedule 13G/A (Amendment No. 3) from Wellington affiliates reporting passive beneficial ownership. The filing lists 8,658,610 shares beneficially owned, representing 5.14% of the common stock as of the event date 09/30/2025.
Wellington reports 0 shares with sole voting or dispositive power, 6,564,421 with shared voting power, and 8,658,610 with shared dispositive power. The securities are held of record by clients of Wellington investment advisers, and no single client is known to hold more than five percent of the class.
American Healthcare REIT (AHR) director Jeffrey T. Hanson reported an open‑market sale of 20,010 shares of common stock on 11/10/2025 at a weighted average price of $49.6804 (Transaction Code S). Following the sale, he held 21,798 shares directly.
He also reports indirect holdings including 54,778 shares by the Hanson Family Trust, 5,552 by April L. Hanson IRA, 2,515 by Crescentridge 401(k), 16,720 by a Defined Benefit Pension Plan, 729 by spouse’s 401(k), and 4,869 by JTH Holdings LLC DBPP. Additionally, 1,268,643 OP Units are held by AHI Group Holdings, LLC; Mr. Hanson disclaims beneficial ownership except to his pecuniary interest.
American Healthcare REIT (AHR) filed a Form 144 notice for a proposed sale of 20,010 shares of common stock. The filing lists an aggregate market value of $994,105, to be transacted through Merrill, with the NYSE named as the exchange and an approximate sale date of 11/10/2025. Shares outstanding were 176,908,238.
The shares to be sold were acquired via restricted stock vesting on several dates, including 10/01/2023 (5,762), 06/15/2024 (3,025), 10/01/2024 (5,762), 02/09/2025 (1,851), and 11/07/2025 (3,610).
American Healthcare REIT, Inc. (AHR) reported a profitable Q3 2025. Total revenues were $572,937,000, up from $523,814,000 a year ago, driven by resident fees and services of $532,058,000. Net income attributable to controlling interest was $55,927,000, or $0.33 per basic and diluted share, compared with a loss in the prior-year quarter.
Expenses rose with property operating costs at $454,530,000 and depreciation and amortization at $49,181,000. Other items included an impairment of real estate investments of $3,768,000 and a gain on re-measurement of a previously held equity interest of $14,580,000. Interest expense, net improved to $20,392,000 from $30,395,000.
For the nine months, operating cash flow reached $239,276,000. The company executed acquisitions totaling $337,978,000 (15 properties) and dispositions of $56,454,000 (12 assets). Cash and cash equivalents increased to $147,364,000, while lines of credit and term loan, net declined to $549,696,000. Shares outstanding were 171,031,062 as of September 30, 2025; 176,908,238 were outstanding as of November 3, 2025.